Skip to Content

L005 (Divalproex Sodium Delayed-Release 125 mg)

Pill with imprint L005 is Purple, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L005

Divalproex sodium delayed-release 125 mg L005

Divalproex Sodium Delayed-Release

Imprint
L005
Strength
125 mg
Color
Purple
Size
11.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc
National Drug Code (NDC)
68180-0265
Inactive Ingredients
D&C Red No. 30, FD&C Blue No. 2, ferric oxide yellow, hypromelloses, silicon dioxide, triethyl citrate, microcrystalline cellulose, hypromellose phthalate (24% phthalate, 55 cst), low substituted hydroxypropyl cellulose, shellac, magnesium silicate, hydroxypropyl cellulose (type h), magnesium stearate, propylene glycol, titanium dioxide, ferrosoferric oxide, pregelatinized corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "L005"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.